IL143149A0 - Stable, attenuated rabies virus mutants and live vaccines thereof - Google Patents

Stable, attenuated rabies virus mutants and live vaccines thereof

Info

Publication number
IL143149A0
IL143149A0 IL14314999A IL14314999A IL143149A0 IL 143149 A0 IL143149 A0 IL 143149A0 IL 14314999 A IL14314999 A IL 14314999A IL 14314999 A IL14314999 A IL 14314999A IL 143149 A0 IL143149 A0 IL 143149A0
Authority
IL
Israel
Prior art keywords
stable
rabies virus
live vaccines
virus mutants
attenuated rabies
Prior art date
Application number
IL14314999A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL143149A0 publication Critical patent/IL143149A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14314999A 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof IL143149A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204001 1998-11-27
PCT/EP1999/009101 WO2000032755A1 (en) 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof

Publications (1)

Publication Number Publication Date
IL143149A0 true IL143149A0 (en) 2002-04-21

Family

ID=8234392

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14314999A IL143149A0 (en) 1998-11-27 1999-11-19 Stable, attenuated rabies virus mutants and live vaccines thereof
IL143149A IL143149A (en) 1998-11-27 2001-05-14 Stable mutants of rabies virus and live vaccines prepared from them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143149A IL143149A (en) 1998-11-27 2001-05-14 Stable mutants of rabies virus and live vaccines prepared from them

Country Status (16)

Country Link
US (1) US6719981B1 (pt)
EP (1) EP1131414B1 (pt)
AR (1) AR021406A1 (pt)
AT (1) ATE356202T1 (pt)
AU (1) AU1386100A (pt)
BR (1) BR9915703B1 (pt)
CA (1) CA2352231C (pt)
CY (1) CY1106570T1 (pt)
DE (1) DE69935445T2 (pt)
DK (1) DK1131414T3 (pt)
ES (1) ES2283150T3 (pt)
ID (1) ID28968A (pt)
IL (2) IL143149A0 (pt)
PT (1) PT1131414E (pt)
TR (1) TR200101445T2 (pt)
WO (1) WO2000032755A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2257505T3 (es) * 2001-04-23 2006-08-01 Akzo Nobel N.V. Mutantes de virus de la rabia atenuados y vacunas vivas correspondientes.
AU2002365029A1 (en) * 2001-07-20 2003-06-10 The University Of Georgia Research Foundation, Inc. Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies
US7863041B2 (en) 2005-10-14 2011-01-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Rabies virus vector systems and compositions and methods thereof
US7785874B2 (en) * 2007-01-11 2010-08-31 The Salk Institute For Biological Studies Compositions and methods for monosynaptic transport
TW200907058A (en) 2007-05-30 2009-02-16 Wyeth Corp Raccoon poxvirus expressing rabies glycoproteins
WO2012106490A1 (en) 2011-02-03 2012-08-09 The Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and filoviruses
CN103865889B (zh) * 2014-04-03 2015-02-25 深圳市卫光生物制品股份有限公司 狂犬病病毒ctn鸡胚细胞适应株
US11041170B2 (en) 2016-04-04 2021-06-22 Thomas Jefferson University Multivalent vaccines for rabies virus and coronaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent
FR2693655B1 (fr) * 1992-07-20 1994-10-14 Virbac Vaccin antirabique avirulent.
SE0002498D0 (sv) 2000-07-03 2000-07-03 Stefan Schwartz Papillomavirus vaccine
AU2002360311A1 (en) 2001-12-10 2003-06-23 Donaldson Company, Inc. Exhaust treatment control system for an internal combustion engine
DE102004009653A1 (de) 2004-02-27 2005-09-22 Cycos Ag Kommunikationsserver und Verfahren zum Aufbau und Betrieb einer Konferenz-Kommunikationsverbindung

Also Published As

Publication number Publication date
CY1106570T1 (el) 2012-01-25
WO2000032755A1 (en) 2000-06-08
EP1131414B1 (en) 2007-03-07
TR200101445T2 (tr) 2001-10-22
US6719981B1 (en) 2004-04-13
DE69935445T2 (de) 2007-11-29
DK1131414T3 (da) 2007-06-18
AR021406A1 (es) 2002-07-17
EP1131414A1 (en) 2001-09-12
BR9915703B1 (pt) 2012-09-04
BR9915703A (pt) 2001-08-14
PT1131414E (pt) 2007-04-30
AU1386100A (en) 2000-06-19
CA2352231A1 (en) 2000-06-08
ID28968A (id) 2001-07-19
ES2283150T3 (es) 2007-10-16
IL143149A (en) 2007-12-03
CA2352231C (en) 2010-06-01
DE69935445D1 (de) 2007-04-19
ATE356202T1 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
GB2337755B (en) Virus vaccine
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
GB9711964D0 (en) Live attenuated vaccines
HUP0103908A3 (en) Novel infulenza virus vaccine composition
EP1112091A4 (en) FAST DEEP TEMPERATURE PRESSURE STERILIZATION AND VACCINE PRODUCTION
ZA200004956B (en) Vaccine composition.
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
ZA200201834B (en) Vaccine against HBV and HPV.
EP0728842A3 (fr) Vaccin vivant recombinant aviaire à base de virus herpès aviaire, notamment contre la maladie de gumboro
AU1508699A (en) Live attenuated influenza vaccine
GB0017720D0 (en) Modified virus
HUP9701586A3 (en) Improved inactivated vaccines
IL143149A0 (en) Stable, attenuated rabies virus mutants and live vaccines thereof
IL137449A0 (en) Live vaccine against brucellosis
GB0027072D0 (en) Vaccine
MXPA03002875A (es) Composicion de vacuna y metodo de estabilizacion.
IL139269A0 (en) Hepatitis vaccine
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
GB9917024D0 (en) Attenuated poliovirus vaccine
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
GB9702990D0 (en) Virus vaccine
IL149173A0 (en) Attenuated recombinant rabies virus mutants and live vaccines thereof
GB9927353D0 (en) Virus preparation and use
GB9620856D0 (en) Virus vaccine
GB9908224D0 (en) Virus preparations and methods

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed